Mortality and causes of death in psoriatic arthritis

Journal of Rheumatology

Volumn 39, Issue SUPPL. 89, 2012, Pages 32-35

  Arumugam, Ramani ^a   McHugh, Neil J ^a  

^a ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

Author keywords

Causes of death; Mortality; Psoriatic arthropathy

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANKYLOSING SPONDYLITIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHRONIC ARTHRITIS; CHRONIC LYMPHATIC LEUKEMIA; CONFERENCE PAPER; DEATH CERTIFICATE; DEMYELINATION; DISEASE SEVERITY; DRUG WITHDRAWAL; HUMAN; INCIDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD; METABOLIC SYNDROME X; MORTALITY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RESPIRATORY TRACT DISEASE; SEPTICEMIA; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; SYSTEMIC VASCULITIS; TH17 CELL; TREND STUDY; TUBERCULOSIS; FEMALE; HOSPITALIZATION; MALE; PATIENT REFERRAL; PROGNOSIS; REGISTER; REVIEW; RISK ASSESSMENT; RISK FACTOR; TIME;

ARTHRITIS, PSORIATIC; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DEATH CERTIFICATES; FEMALE; HUMANS; MALE; PROGNOSIS; REFERRAL AND CONSULTATION; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84864401441     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120239     Document Type: Conference Paper

References (19)

1. Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PSA) - an analysis of 220 patients. Q J Med 1987;62:127-41. (Pubitemid 17042878)
2. Torre Alonso JC, Rodriguez Perez A, Arribas Castrillo JM, Ballina Garcia J, Riestra Noriega JL, Lopez Larrea C. Psoriatic arthritis (PA): A clinical, immunologic and radiological study of 180 patients. Br J Rheumatol 1991;30:245-50.
3. Gladman DD. Natural history of psoriatic arthritis. Baillière's Clin Rheumatol 1994;8:379-94. (Pubitemid 24189845)
4. Wong K, Gladman DD, Husted J, Long JA, Farewell VT. Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 1997;40:1868-72. (Pubitemid 27452539)
5. Ali Y, Tom BD, Schentag CT, Farewell VT, Gladman DD. Improved survival in psoriatic arthritis with calendar time. Arthritis Rheum 2007;56:2708-14. (Pubitemid 47237289)
6. Shbeeb M, Uramoto KM, Gibson LE, O'Fallon WM, Gabriel SE. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 2000;27:1247-50. (Pubitemid 30262512)
7. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a population based study. J Rheumatol 2009;36:361-7.
8. Buckley, Cavill C, Taylor G, Kay H, Waldron N, Korendowych E. Mortality in psoriatic arthritis - a single-center study from the UK. J Rheumatol 2010;37:2141-4.
9. Mok CC, Kwok CL, Ho LY, Chan PT, Yip SF. Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum 2011;63:1182-9.
10. Mallbris L, Akre O, Granath F, Yin L, Lindelöf B, Ekbom A, et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004;19:225-30. (Pubitemid 38461682)
11. Gelfand JM, Troxel AB, Lewis JD, Kurd SK, Shin DB, Wang X, et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 2007;143:1493-9. (Pubitemid 350277763)
12. Eder L, Zisman D, Barzilai M, Laor A, Rahat M, Rozenbaum M, et al. Subclinical atherosclerosis in psoriatic arthritis: a case-control study. J Rheumatol 2008;35:877-82. (Pubitemid 351747131)
13. Jones SM, Harris CPD, Lloyd J, Reckless JPD, McHugh NJ. Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease. Ann Rheum Dis 2000;59:904-9.
14. Ramonda R, Lo Nigro A, Modesti V, Nalotto L, Musacchio E, Iaccarino L, et al. Atherosclerosis in psoriatic arthritis. Autoimmun Rev 2011;10:773-8.
15. Angel K, Provan SA, Gulseth HL, Mowinckel P, Kvien TK, Atar D. Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study. Hypertension 2010;55:333-8.
16. Alamanos Y, Papadopoulos NG, Voulgari PV, Siozos C, Psychos DN, Tympanidou M, et al. Epidemiology of psoriatic arthritis in northwest Greece, 1982-2001. J Rheumatol 2003;30:2641-4. (Pubitemid 37549344)
17. Dixon WG, Watson KD, Lunt M, Hyrich KL; British Society for Rheumatology Biologics Register Control Centre Consortium, Silman AJ, Symmons DP; British Society for Rheumatology Biologics Register. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2007;56:2905-12. (Pubitemid 47502736)
18. Heiberg MS, Kaufmann C, Rodevand E, Mikkelsen K, Koldingsnes W, Mowinckel R, et al. The comparative effectiveness of anti-TNF therapy and Methotrexate in patients with psoriatic arthritis; 6 month results from a longitudinal, observational, multicentre study. Ann Rheum Dis 2007;66:1038-42. (Pubitemid 47122316)
19. Kristensen LE, Gulfe A, Saxne T, Geborek P. Efficacy and tolerability of anti-tumur necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register. Ann Rheum Dis 2008;67:364-9. (Pubitemid 351281272)